• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型黄嘌呤氧化酶抑制剂TEI-6720对啮齿动物的降尿酸作用。

Hypouricemic effect of the novel xanthine oxidase inhibitor, TEI-6720, in rodents.

作者信息

Osada Y, Tsuchimoto M, Fukushima H, Takahashi K, Kondo S, Hasegawa M, Komoriya K

机构信息

Teijin Institute for Bio-medical Research, Tokyo, Japan.

出版信息

Eur J Pharmacol. 1993 Sep 14;241(2-3):183-8. doi: 10.1016/0014-2999(93)90201-r.

DOI:10.1016/0014-2999(93)90201-r
PMID:8243554
Abstract

We investigated the xanthine oxidase/xanthine dehydrogenase inhibitory activity and hypouricemic effect of a newly synthesized xanthine oxidase/xanthine dehydrogenase inhibitor, TEI-6720, 2-(3-cyano-4-isobutoxyphenyl)-4-methyl-5-thiazole-carboxylic acid, and compared its effects with those of allopurinol in rodents. TEI-6720 was found to inhibit bovine milk xanthine oxidase, and mouse liver and rat liver xanthine oxidase/xanthine dehydrogenase with IC50 values of 1.4, 1.8 and 2.2 nM, respectively. On bovine milk xanthine oxidase, TEI-6720 exhibited mixed-type inhibition and the Ki value was 0.7 nM. TEI-6720 displayed prolonged urate-lowering activity in normal mice and rats. We evaluated the hypouricemic effect of TEI-6720 on hyperuricemia induced by the uricase inhibitor, potassium oxonate (250 mg/kg s.c., 1 h before the test drugs), and measured the total molarity of both serum allantoin and urate in rats. Oral TEI-6720 and allopurinol had a hypouricemic effect 2 h after their administration to oxonate-pretreated rats with ED50 values of 1.5 and 5.0 mg/kg, respectively. Both compounds also reduced the combined molarity of uric acid and allantoin in rats. The ED50 values of TEI-6720 and allopurinol were 2.1 and 6.9 mg/kg p.o., respectively. These results suggest that TEI-6720 may be useful for the treatment of hyperuricemia.

摘要

我们研究了一种新合成的黄嘌呤氧化酶/黄嘌呤脱氢酶抑制剂TEI-6720(2-(3-氰基-4-异丁氧基苯基)-4-甲基-5-噻唑羧酸)的黄嘌呤氧化酶/黄嘌呤脱氢酶抑制活性和降尿酸作用,并在啮齿动物中将其效果与别嘌醇进行了比较。结果发现,TEI-6720可抑制牛乳黄嘌呤氧化酶以及小鼠肝脏和大鼠肝脏中的黄嘌呤氧化酶/黄嘌呤脱氢酶,其IC50值分别为1.4、1.8和2.2 nM。对于牛乳黄嘌呤氧化酶,TEI-6720表现出混合型抑制作用,其Ki值为0.7 nM。TEI-6720在正常小鼠和大鼠中显示出持久的尿酸降低活性。我们评估了TEI-6720对尿酸酶抑制剂氧嗪酸钾(250 mg/kg皮下注射,在测试药物前1小时)诱导的高尿酸血症的降尿酸作用,并测量了大鼠血清中尿囊素和尿酸盐的总摩尔浓度。口服TEI-6720和别嘌醇在给氧嗪酸钾预处理的大鼠给药2小时后具有降尿酸作用,其ED50值分别为1.5和5.0 mg/kg。两种化合物还降低了大鼠尿酸和尿囊素的总摩尔浓度。TEI-6720和别嘌醇的口服ED50值分别为2.1和6.9 mg/kg。这些结果表明,TEI-6720可能对高尿酸血症的治疗有用。

相似文献

1
Hypouricemic effect of the novel xanthine oxidase inhibitor, TEI-6720, in rodents.新型黄嘌呤氧化酶抑制剂TEI-6720对啮齿动物的降尿酸作用。
Eur J Pharmacol. 1993 Sep 14;241(2-3):183-8. doi: 10.1016/0014-2999(93)90201-r.
2
Hypouricemic effect of allopurinol and the novel xanthine oxidase inhibitor TEI-6720 in chimpanzees.别嘌醇及新型黄嘌呤氧化酶抑制剂TEI-6720对黑猩猩的降尿酸作用
Eur J Pharmacol. 1993 Dec 21;250(3):455-60. doi: 10.1016/0014-2999(93)90033-e.
3
A comparative study on the hypouricemic activity and potency in renal xanthine calculus formation of two xanthine oxidase/xanthine dehydrogenase inhibitors: TEI-6720 and allopurinol in rats.两种黄嘌呤氧化酶/黄嘌呤脱氢酶抑制剂TEI-6720和别嘌呤醇对大鼠降尿酸活性及肾性黄嘌呤结石形成影响的比较研究
Res Commun Mol Pathol Pharmacol. 1999;104(3):307-19.
4
Aesculin possesses potent hypouricemic action in rodents but is devoid of xanthine oxidase/dehydrogenase inhibitory activity.七叶苷在啮齿动物中具有强大的降尿酸作用,但缺乏黄嘌呤氧化酶/脱氢酶抑制活性。
Planta Med. 2002 Feb;68(2):175-8. doi: 10.1055/s-2002-20262.
5
Synthesis and structure-activity relationships of 1-phenylpyrazoles as xanthine oxidase inhibitors.1-苯基吡唑类作为黄嘌呤氧化酶抑制剂的合成及其构效关系
Bioorg Med Chem Lett. 2001 Apr 9;11(7):879-82. doi: 10.1016/s0960-894x(01)00093-2.
6
Febuxostat: a selective xanthine-oxidase/xanthine-dehydrogenase inhibitor for the management of hyperuricemia in adults with gout.非布司他:一种选择性黄嘌呤氧化酶/黄嘌呤脱氢酶抑制剂,用于治疗成人痛风患者的高尿酸血症。
Clin Ther. 2009 Nov;31(11):2503-18. doi: 10.1016/j.clinthera.2009.11.033.
7
Effects of cassia oil on serum and hepatic uric acid levels in oxonate-induced mice and xanthine dehydrogenase and xanthine oxidase activities in mouse liver.桂皮油对氧嗪酸钾诱导的小鼠血清和肝脏尿酸水平以及小鼠肝脏黄嘌呤脱氢酶和黄嘌呤氧化酶活性的影响。
J Ethnopharmacol. 2006 Feb 20;103(3):357-65. doi: 10.1016/j.jep.2005.08.040. Epub 2005 Sep 22.
8
Administration of procyanidins from grape seeds reduces serum uric acid levels and decreases hepatic xanthine dehydrogenase/oxidase activities in oxonate-treated mice.给草酸盐处理的小鼠施用葡萄籽原花青素可降低血清尿酸水平,并降低肝脏黄嘌呤脱氢酶/氧化酶活性。
Basic Clin Pharmacol Toxicol. 2004 May;94(5):232-7. doi: 10.1111/j.1742-7843.2004.pto940506.x.
9
Selectivity of febuxostat, a novel non-purine inhibitor of xanthine oxidase/xanthine dehydrogenase.非布司他(一种新型黄嘌呤氧化酶/黄嘌呤脱氢酶非嘌呤抑制剂)的选择性
Life Sci. 2005 Mar 4;76(16):1835-47. doi: 10.1016/j.lfs.2004.10.031. Epub 2005 Jan 18.
10
Effects of Biota orientalis extract and its flavonoid constituents, quercetin and rutin on serum uric acid levels in oxonate-induced mice and xanthine dehydrogenase and xanthine oxidase activities in mouse liver.侧柏叶提取物及其黄酮类成分槲皮素和芦丁对氧嗪酸钾诱导的小鼠血清尿酸水平以及小鼠肝脏黄嘌呤脱氢酶和黄嘌呤氧化酶活性的影响。
J Ethnopharmacol. 2004 Jul;93(1):133-40. doi: 10.1016/j.jep.2004.03.037.

引用本文的文献

1
Metabolic constraint of human telomere length by nucleotide salvage efficiency.核苷酸补救效率对人类端粒长度的代谢限制
Nat Commun. 2025 Mar 27;16(1):3000. doi: 10.1038/s41467-025-58221-7.
2
Density functional theory (DFT), molecular docking, and xanthine oxidase inhibitory studies of dinaphthodiospyrol S from L.来自[植物名称未完整给出]的二萘双环氧木质素S的密度泛函理论(DFT)、分子对接及黄嘌呤氧化酶抑制研究
Saudi Pharm J. 2024 Feb;32(2):101936. doi: 10.1016/j.jsps.2023.101936. Epub 2023 Dec 26.
3
Computational Characterization of the Inhibition Mechanism of Xanthine Oxidoreductase by Topiroxostat.
托匹司他对黄嘌呤氧化还原酶抑制机制的计算表征
ACS Catal. 2023 May 5;13(9):6023-6043. doi: 10.1021/acscatal.3c01245. Epub 2023 Apr 18.
4
Investigation of the Inhibition Mechanism of Xanthine Oxidoreductase by Oxipurinol: A Computational Study.黄嘌呤氧化酶抑制剂别嘌呤醇抑制机制的研究:计算研究。
J Chem Inf Model. 2023 Jul 10;63(13):4190-4206. doi: 10.1021/acs.jcim.3c00624. Epub 2023 Jun 15.
5
OAT10/SLC22A13 Acts as a Renal Urate Re-Absorber: Clinico-Genetic and Functional Analyses With Pharmacological Impacts.OAT10/SLC22A13作为肾脏尿酸重吸收体:临床遗传学及药理学影响的功能分析
Front Pharmacol. 2022 Apr 6;13:842717. doi: 10.3389/fphar.2022.842717. eCollection 2022.
6
A Novel Use of Allopurinol as A Quorum-Sensing Inhibitor in .别嘌醇作为群体感应抑制剂的一种新用途 于…… (原文此处不完整)
Antibiotics (Basel). 2021 Nov 12;10(11):1385. doi: 10.3390/antibiotics10111385.
7
Increased plasma disequilibrium between pro- and anti-oxidants during the early phase resuscitation after cardiac arrest is associated with increased levels of oxidative stress end-products.在心脏骤停后早期复苏期间,血浆中促氧化剂和抗氧化剂之间的平衡增加与氧化应激终产物水平的增加有关。
Mol Med. 2021 Oct 24;27(1):135. doi: 10.1186/s10020-021-00397-x.
8
Identification of Modulators of HIV-1 Proviral Transcription from a Library of FDA-Approved Pharmaceuticals.从 FDA 批准的药物文库中鉴定 HIV-1 前病毒转录的调节剂。
Viruses. 2020 Sep 23;12(10):1067. doi: 10.3390/v12101067.
9
Xanthine Oxidase/Dehydrogenase Activity as a Source of Oxidative Stress in Prostate Cancer Tissue.黄嘌呤氧化酶/脱氢酶活性作为前列腺癌组织氧化应激的一个来源
Diagnostics (Basel). 2020 Sep 3;10(9):668. doi: 10.3390/diagnostics10090668.
10
Effects of Febuxostat on Mortality and Cardiovascular Outcomes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.非布司他对死亡率和心血管结局的影响:随机对照试验的系统评价和荟萃分析
Mayo Clin Proc Innov Qual Outcomes. 2020 Aug 5;4(4):434-442. doi: 10.1016/j.mayocpiqo.2020.04.012. eCollection 2020 Aug.